BINEX Co., Ltd. (KOSDAQ:053030)
15,890
+960 (6.43%)
At close: Feb 27, 2026
BINEX Market Cap
BINEX has a market cap or net worth of 506.06 billion as of February 27, 2026. Its market cap has decreased by -29.53% in one year.
Market Cap
506.06B
Enterprise Value
582.21B
Revenue
165.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
15,890.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 506.06B, an increase of 1,901.34%. That is a compound annual growth rate of 13.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 506.06B | 6.07% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 904.14B |
| Proteina | 898.13B |
| MEDIPOST | 857.93B |
| Green Cross Holdings | 723.25B |
| Genomictree | 503.53B |
| SillaJen | 500.03B |
| GC Cell | 380.19B |
| Anterogen.Co.,Ltd. | 359.22B |